[Effect of oral administration of 2-bromo-alpha-ergocriptine on blood glucose, serum IRI and HGH levels in normal subjects and diabetics (author's transl)].
D000328:Adult; D001786:Blood Glucose / Q000378:metabolism*; D001971:Bromocriptine / Q000494:pharmacology*; D003920:Diabetes Mellitus / Q000097:blood / Q000378:metabolism* / Q000503:physiopathology; D005260:Female; D005947:Glucose / Q000378:metabolism; D005951:Glucose Tolerance Test; D013006:Growth Hormone / Q000097:blood*; D006801:Humans; D007031:Hypothalamus / Q000502:physiology*; D007328:Insulin / Q000097:blood*; D008297:Male; D008875:Middle Aged; D011863:Radioimmunoassay; D011955:Receptors, Drug
D001786:Blood Glucose; D007328:Insulin; D011955:Receptors, Drug; D001971:Bromocriptine; D013006:Growth Hormone; D005947:Glucose